Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 8/20 | 0.68 |
| ▸ | BLM | P54132 | 4/20 | 0.67 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.67 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.66 |
| ▸ | CHRM5 | P08912 | 6/20 | 0.64 |
| ▸ | CHRM1 | P11229 | 6/20 | 0.64 |
| ▸ | CHRM3 | P20309 | 5/20 | 0.64 |
| ▸ | CHRM4 | P08173 | 4/20 | 0.64 |
| ▸ | MEN1 | O00255 | 3/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.64 |
| ▸ | TSHR | P16473 | 2/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.56 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fentonium SCHEMBL24584 | 0.99 | BLM (0.69) | CHRM2BLMPABPC1CYP2C19CHRM5 | |
| Fentonium SCHEMBL30186606 | 0.99 | BLM (0.69) | CHRM2BLMPABPC1CYP2C19CHRM5 | |
| Fentonium SCHEMBL24583 | 0.99 | BLM (0.69) | CHRM2BLMPABPC1CYP2C19CHRM5 | |
| Fentonium SCHEMBL13724144 | 0.89 | CHRM1 (0.58) | CHRM2BLMPABPC1CYP2C19CHRM5 | |
| Xenytropium SCHEMBL30428452 | 0.86 | CHRM2 (0.71) | CHRM2BLMPABPC1CYP2C19CHRM5 | |
| Xenytropium SCHEMBL29361010 | 0.86 | CHRM2 (0.71) | CHRM2BLMPABPC1CYP2C19CHRM5 | |
| Xenytropium SCHEMBL29371652 | 0.85 | BLM (0.71) | CHRM2BLMPABPC1CYP2C19CHRM5 | |
| Xenytropium SCHEMBL24707 | 0.85 | BLM (0.71) | CHRM2BLMPABPC1CYP2C19CHRM5 | |
| SCHEMBL14507225 | 0.83 | CHRM2 (0.80) | CHRM2BLMPABPC1CYP2C19CHRM5 | |
| Fentonium SCHEMBL5561324 | 0.82 | MEN1 (0.49) | CHRM2BLMPABPC1CYP2C19CHRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 178 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11065205-B2 | Immediate/delayed drug delivery | DRUG DELIVERY INTERNATIONAL LIMITED (GB) | 2021-07-20 | — | — | US | claimed |
| US-20190125679-A1 | IMMEDIATE/DELAYED DRUG DELIVERY | UNIVERSITY OF STRATHCLYDE (GB) | 2019-05-02 | — | — | US | claimed |
| EP-3373943-A1 | CONTROL OF CELLULAR REDOX LEVELS | Mckenna, Elizabeth (US) | 2018-09-19 | — | — | EP | claimed |
| EP-2956450-B1 | HYDROXYINDALPINE DERIVATIVES AND THEIR MEDICAL USE | UNIV MUENCHEN TECH (DE) | 2018-07-25 | — | — | EP | claimed |
| EP-2542228-B1 | PULSATILE DRUG RELEASE | UNIV STRATHCLYDE (GB) | 2017-11-29 | — | — | EP | claimed |
| EP-2542227-B1 | IMMEDIATE/DELAYED DRUG DELIVERY | UNIV STRATHCLYDE (GB) | 2017-11-22 | — | — | EP | claimed |
| EP-2542226-B1 | DELAYED PROLONGED DRUG DELIVERY | UNIV STRATHCLYDE (GB) | 2017-11-22 | — | — | EP | claimed |
| WO-2017083470-A1 | CONTROL OF CELLULAR REDOX LEVELS | MCKENNA ELIZABETH (US) | 2017-05-18 | — | — | WO | claimed |
| US-9474719-B2 | Pulsatile drug release | UNIVERSITY OF STRATHCLYDE (GB) | 2016-10-25 | — | — | US | claimed |
| US-9283192-B2 | Delayed prolonged drug delivery | UNIVERSITY OF STRATHCLYDE (GB) | 2016-03-15 | — | — | US | claimed |
| WO-2011107749-A2 | PULSATILE DRUG RELEASE | UNIVERSITY OF STRATHCLYDE (GB) | 2011-09-09 | — | — | WO | claimed |
| WO-2011107750-A2 | DELAYED PROLONGED DRUG DELIVERY | UNIVERSITY OF STRATHCLYDE (GB) | 2011-09-09 | — | — | WO | claimed |
| WO-2011107755-A2 | IMMEDIATE/DELAYED DRUG DELIVERY | UNIVERSITY OF STRATHCLYDE (GB) | 2011-09-09 | — | — | WO | claimed |
| US-20100226943-A1 | SURFACE TOPOGRAPHIES FOR NON-TOXIC BIOADHESION CONTROL | UNIVERSITY OF FLORIDA (US) | 2010-09-09 | — | — | US | claimed |
| CN-101330905-A | Freeze-drying process and products obtained thereby | SCIDOSE LLC (US) | 2008-12-24 | — | — | CN | claimed |
| EP-1954244-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | Scidose, Llc (US) | 2008-08-13 | — | — | EP | claimed |
| WO-2007061529-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | SCIDOSE LLC. (US) | 2007-05-31 | — | — | WO | claimed |
| US-20070116729-A1 | Lyophilization process and products obtained thereby | SCIDOSE LLC | 2007-05-24 | — | — | US | claimed |
| EP-1273301-B1 | Pharmaceutical preparations based on active ingredients susceptible to illicit administration | ALTERGON SA (CH) | 2006-09-06 | — | — | EP | claimed |
| US-5779661-A | Method of treating dysfunctional bladder syndromes by electromotive drug administration | PHYSION, S.R.L. (IT) | 1998-07-14 | — | — | US | claimed |